Lilleberg J - Search Results

1

Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting.

Lilleberg J, Nieminen MS, Akkila J, Heikkilä L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenperä M. Lilleberg J, et al. Eur Heart J. 1998 Apr;19(4):660-8. doi: 10.1053/euhj.1997.0806. Eur Heart J. 1998. PMID: 9597417 Clinical Trial.

2

Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men.

Sundberg S, Lilleberg J, Nieminen MS, Lehtonen L. Sundberg S, et al. Among authors: lilleberg j. Am J Cardiol. 1995 May 15;75(15):1061-6. doi: 10.1016/s0002-9149(99)80725-5. Am J Cardiol. 1995. PMID: 7747690 Clinical Trial.

3

Haemodynamic dose-efficacy of levosimendan in healthy volunteers.

Lilleberg J, Sundberg S, Häyhä M, Akkila J, Nieminen MS. Lilleberg J, et al. Eur J Clin Pharmacol. 1994;47(3):267-74. doi: 10.1007/BF02570507. Eur J Clin Pharmacol. 1994. PMID: 7867680

4

Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers.

Lilleberg J, Antila S, Karlsson M, Nieminen MS, Pentkäinen PJ. Lilleberg J, et al. Clin Pharmacol Ther. 1994 Nov;56(5):554-63. doi: 10.1038/clpt.1994.177. Clin Pharmacol Ther. 1994. PMID: 7955820 Clinical Trial.

5

Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction.

Lilleberg J, Sundberg S, Nieminen MS. Lilleberg J, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 1:S63-9. J Cardiovasc Pharmacol. 1995. PMID: 8907133 Clinical Trial.

6

Hemodynamic effects of the novel cardiotonic drug simendan: echocardiographic assessment in healthy volunteers.

Lilleberg JM, Sundberg S, Leikola-Pelho T, Nieminen MS. Lilleberg JM, et al. Cardiovasc Drugs Ther. 1994 Apr;8(2):263-9. doi: 10.1007/BF00877335. Cardiovasc Drugs Ther. 1994. PMID: 7918139 Clinical Trial.

7

The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies.

Lilleberg J, Ylönen V, Lehtonen L, Toivonen L. Lilleberg J, et al. Scand Cardiovasc J. 2004 May;38(2):80-4. doi: 10.1080/14017430410025783. Scand Cardiovasc J. 2004. PMID: 15204232

8

Outcome up to one year following different reperfusion strategies in acute ST-segment elevation myocardial infarction: the Helsinki-Uusimaa Hospital District registry of ST-Elevation Acute Myocardial Infarction (HUS-STEMI).

Viikilä J, Lilleberg J, Tierala I, Syvänne M, Kupari M, Salomaa V, Nieminen MS; HUS-STEMI Investigators. Viikilä J, et al. Among authors: lilleberg j. Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):371-8. doi: 10.1177/2048872613501985. Epub 2013 Aug 21. Eur Heart J Acute Cardiovasc Care. 2013. PMID: 24338296 Free PMC article.

9

Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.

Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M. Lilleberg J, et al. Eur J Heart Fail. 2007 Jan;9(1):75-82. doi: 10.1016/j.ejheart.2006.04.012. Epub 2006 Jul 7. Eur J Heart Fail. 2007. PMID: 16829185 Free article. Clinical Trial.

10

Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Helve S, Viikilä J, Laine M, Lilleberg J, Tierala I, Nieminen T. Helve S, et al. Among authors: lilleberg j. BMC Cardiovasc Disord. 2014 Sep 10;14:115. doi: 10.1186/1471-2261-14-115. BMC Cardiovasc Disord. 2014. PMID: 25204401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page